UDP-glucuronosyltransferases (UGTs) are essential phase II drug-metabolizing enzymes that facilitate the detoxification of various substances, whose dysregulation can lead to metabolic disorders and improper management of xenobiotics. Here, B3GAT2 is linked to metabolic disease.